Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Optimal therapeutic strategies for mixed phenotype acute leukemia.

Current opinion in hematology - 1 Mar 2020

Wolach Ofir, Stone Richard M

Abstract excerpt

PURPOSE OF REVIEW: Mixed phenotype acute leukemia (MPAL) encompasses a rare group of clinically, immunophenotypically, and genetically diverse leukemias. Diagnosing and treating these patients remains challenging. In recent years, systematic efforts have been made to better define the genetic landscape of MPAL. These insights allow better understanding of the pathophysiology of MPAL, have the potential for a more...

Topics

Humans
Leukemia, Myeloid, Acute
Phenotype

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 31913151
DOI: 10.1097/MOH.0000000000000570

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Optimal therapeutic strategies for mixed phenotype acute leukemia.PMID 31913151Read ↗

Mixed-Phenotype Acute Leukemia: Clinical Diagnosis and Therapeutic StrategiesSemantic proximity Read ↗

Mixed-phenotype acute leukemia: current challenges in diagnosis and therapy.Semantic proximity Read ↗

An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL).Semantic proximity Read ↗

Pediatric Mixed-Phenotype Acute Leukemia: What’s New?Semantic proximity Read ↗

The genomic and biological complexity of mixed phenotype acute leukemia.Semantic proximity Read ↗

Genomic Landscape of Mixed-Phenotype Acute Leukemia.Semantic proximity Read ↗

Genomic Landscape of Mixed Phenotype Acute Leukemia Associated With Immunophenotypic Lineage Predominance: Impact on Diagnosis and TreatmentSemantic proximity Read ↗

Mixed-phenotype acute leukemia: historical overview and a new definition.Semantic proximity Read ↗

Mixed-phenotype acute leukemia: state-of-the-art of the diagnosis, classification and treatment.Semantic proximity Read ↗

Mixed Phenotype/Lineage Leukemia: Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?Semantic proximity Read ↗

How I treat mixed-phenotype acute leukemiaSemantic proximity Read ↗

Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.